Marion Merrell Dow's Rifater
Combination of 120 mg rifampin, 50 mg isoniazid and 300 mg pyrazinamide for initial treatment of pulmonary tuberculosis has an AWP of $108 for 60 tablets, according to the November Medi- Span. The drug was approved May 31 ("The Pink Sheet" June 6, T&G- 1)
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth